Myelodysplastic Syndromes

Latest News

Distinct Molecular Profiles in Younger vs Older Patients With MDS Identified in New Study
Distinct Molecular Profiles in Younger vs Older Patients With MDS Identified in New Study

December 25th 2022

The relationship between aging and molecular profiles in myelodysplastic syndromes (MDS) is not well understood, but the findings suggest that different genetic alterations have distinct prognostic implications in different age groups.

ICYMI: Top Content From EHA22
ICYMI: Top Content From EHA22

December 22nd 2022

ASXL1 Mutations Associated With Worse Prognosis in MDS and AML
ASXL1 Mutations Associated With Worse Prognosis in MDS and AML

December 18th 2022

Study Identifies Sex-Related Differences in MDS Phenotypes, Genotypes, and Outcomes
Study Identifies Sex-Related Differences in MDS Phenotypes, Genotypes, and Outcomes

December 12th 2022

Phase 3 Trials in High-Risk MDS Highlight Future Directions
Phase 3 Trials in High-Risk MDS Highlight Future Directions

December 9th 2022

Video Interviews

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.